Literature DB >> 17705674

Family history of diabetes mellitus determines insulin sensitivity and beta cell function in polycystic ovary syndrome.

J Vrbíková1, T Grimmichová, K Dvořáková, M Hill, S Stanická, K Vondra.   

Abstract

OBJECTIVE: To examine the impact of family history of diabetes mellitus 2 (DM 2) on insulin sensitivity and secretion in lean women with polycystic ovary syndrome (PCOS). Thirteen healthy women (C), 14 PCOS without family history of DM 2 (FH-) and 8 PCOS with family history of DM 2 (FH+) were examined using euglycemic hyperinsulinemic clamp and an arginine secretion test (insulin and glucagon at fasting glycemia (AIR(FG) and AGR(FG)) and at hyperglycemia (AIR(14) and AGR(14)). FH+ women were more insulin resistant than FH- with lower insulin sensitivity index corrected per lean body mass (p 0.05). They had significantly higher triglycerides (p 0.05) and lower HDL-cholesterol (p 0.05) than C or FH- women. Concerning insulin secretion, AIR(FG) was increased in FH+ women comparing FH- women (p 0.05). Disposition indices derived from AIR(FG) or AIR(14) and insulin sensitivity index did not differ between FH+ or FH-. Thus, women with PCOS with the concomitant family history of DM 2 have lower insulin sensitivity than healthy control women. Insulin resistance observed in these women with PCOS is compensated by increased insulin secretion.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17705674     DOI: 10.33549/physiolres.931275

Source DB:  PubMed          Journal:  Physiol Res        ISSN: 0862-8408            Impact factor:   1.881


  6 in total

1.  Insulin resistance in nonobese Japanese women with polycystic ovary syndrome is associated with poorer glucose tolerance, delayed insulin secretion, and enhanced insulin response.

Authors:  Hiroaki Negishi; Kazuki Nakao; Michiko Kimura; Hiroshi Takenaka; Michiharu Horikawa
Journal:  Reprod Med Biol       Date:  2015-03-19

2.  Pancreatic β-cell dysfunction in polycystic ovary syndrome: the role of metformin.

Authors:  Caroline Messer; Raymond Boston; Derek Leroith; Eliza Geer; Joshua D Miller; Marcelo Messer; Walter Futterweit
Journal:  Endocr Pract       Date:  2012 Sep-Oct       Impact factor: 3.443

3.  Influence of Insulin on LH, Testosterone and SHBG in various PCOS Categories based on the Mode of Secretion of LH in relation to FSH Levels.

Authors:  N A Malini; G K Roy
Journal:  Acta Endocrinol (Buchar)       Date:  2021 Jul-Sep       Impact factor: 0.877

4.  PLASMA NEPRILYSIN LEVELS IN PATIENTS WITH POLYCYSTIC OVARY SYNDROME.

Authors:  O Oz Gul; P Sisman; S Cander; E Sarandol; C Ersoy; E Erturk
Journal:  Acta Endocrinol (Buchar)       Date:  2022 Jan-Mar       Impact factor: 1.104

5.  Endocrinological and metabolic characteristics in patients who are non-obese and have polycystic ovary syndrome and different types of a family history of type 2 diabetes mellitus.

Authors:  Yuan Wang; Hua Gao; Wen Di; Zhuowei Gu
Journal:  J Int Med Res       Date:  2021-05       Impact factor: 1.671

6.  Insulin dynamics in young women with polycystic ovary syndrome and normal glucose tolerance across categories of body mass index.

Authors:  Melania Manco; Lidia Castagneto-Gissey; Eugenio Arrighi; Annamaria Carnicelli; Claudia Brufani; Rosa Luciano; Geltrude Mingrone
Journal:  PLoS One       Date:  2014-04-04       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.